her2 testing in metastaticcolorectal cancer (mcrc)
Published 10 months ago • 215 plays • Length 1:04:45Download video MP4
Download video MP3
Similar videos
-
1:54
her2 testing in metastatic colorectal cancer (mcrc)| free webinar| pathology hub
-
1:08
targeting her2 in colorectal cancer
-
31:17
molecular testing and the role of her2 in managing advanced colorectal cancer
-
36:12
her2-positive metastatic colorectal cancer: unraveling game-changing treatment approaches
-
8:12
her2 testing in metastatic breast cancer
-
3:24
her2 testing in gastroesophageal cancers
-
1:23
pathologist dr. elizabeth hammond discusses the asco/cap her2 testing guideline revisions
-
2:07
recommendations for her2 testing in metastatic breast cancer
-
20:48
s1 episode 4: breakthroughs in her2-amplified colorectal cancer
-
36:00
updates in her2 testing in breast cancer
-
1:11
32 month follow-up of mountaineer: tucatinib and trastuzumab in her2 mcrc
-
1:20
dr. corcoran on targeting her2 amplification in crc
-
46:51
her2 in breast cancer: testing guidelines and new treatment approaches
-
34:27
fulfilling the potential of her2-targeting in colorectal cancer: update on detection and management
-
1:07
targeting her2 in colorectal cancer
-
0:43
how will the mountaineer trial affect the her2-positive mcrc treatment landscape?
-
1:14
updated analysis from mountaineer: tucatinib and trastuzumab for her2-positive mcrc
-
7:09
molecular testing in 2019 for mcrc
-
1:23
tucatinib and trastuzumab in the treatment paradigm of her2-positive mcrc